KDR and lung cancer: Here, we present cannabinoid receptor-dependent antiangiogenic properties of JZL184 due to decreased expression of VEGF in hypoxic lung cancer cells, which in turn leads to decreased activation of VEGF receptor 2 (VEGFR2) in HUVECs.